Cardiovascular Outcomes Trials (CVOT) and Diabetes: the Clinical Landscape

Cardiovascular Outcomes Trials (CVOT) and Diabetes: the Clinical Landscape is organized by Baptist Health South Florida.

Release Date: Nov 01, 2018
End Date: Nov 01, 2020    

Accreditation:
• 1.00 AMA PRA Category 1 Credit™
• 1.00 Florida Board of Nursing
• 1.00 Nurse Practitioners
• 1.00 Florida Board of Pharmacy
• 1.00 General certificate of attendance

Description:
Review clinical trials supporting medication management in diabetes patients to reduce the risk of cardiovascular events.

Learning Objectives:
• Evaluate the excess risk of cardiovascular disease (CVD) associated with diabetes mellitus compared to nondiabetic patients.
• Evaluate the evidence that the use of SGLT2 inhibitors and GLP-1 agonists in diabetic patients is associated with the reduction of CVD.
• Describe the mechanisms of action for the reduction of CVD with SGLT2 inhibitors and GLP-1 agonists and the lack of relationship to reduction in A1C.